Encompass Health Corporation Revenue
Encompass Health Corporation (EHC) reported Revenue of $1.60 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-07
- Encompass Health Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $1.60B, a 9.58% increase year-over-year.
- Encompass Health Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $1.59B, a 9.01% increase year-over-year.
- Encompass Health Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $1.54B, a 9.94% increase year-over-year.
- Encompass Health Corporation revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $1.48B, a 9.36% increase year-over-year.
- Encompass Health Corporation revenue from contract with customer, excluding assessed tax for fiscal 2025 was $5.94B, a 10.46% increase from fiscal 2024.
- Encompass Health Corporation revenue from contract with customer, excluding assessed tax for fiscal 2024 was $5.37B, a 11.91% increase from fiscal 2023.
- Encompass Health Corporation revenue from contract with customer, excluding assessed tax for fiscal 2023 was $4.80B, a 10.41% increase from fiscal 2022.
- Encompass Health Corporation revenue from contract with customer, excluding assessed tax for fiscal 2022 was $4.35B, a 8.31% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.60B 10-Q · filed 2026-08-07 | $3.18B 10-Q · filed 2026-08-07 | $4.73B derived: sum of 3 quarters · filed 2026-08-07 | $6.21B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $1.59B 10-Q · filed 2026-05-01 | $3.13B derived: sum of 2 quarters · filed 2026-05-01 | $4.61B derived: sum of 3 quarters · filed 2026-05-01 | $6.07B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $1.54B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.02B derived: sum of 2 quarters · filed 2026-02-26 | $4.48B derived: sum of 3 quarters · filed 2026-08-07 | $5.94B 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $1.48B 10-Q · filed 2025-10-31 | $2.94B derived: sum of 2 quarters · filed 2026-08-07 | $4.39B 10-Q · filed 2025-10-31 | $5.80B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $1.46B 10-Q · filed 2026-08-07 | $2.91B 10-Q · filed 2026-08-07 | $4.32B derived: sum of 3 quarters · filed 2026-08-07 | $5.67B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $1.46B 10-Q · filed 2026-05-01 | $2.86B derived: sum of 2 quarters · filed 2026-05-01 | $4.21B derived: sum of 3 quarters · filed 2026-05-01 | $5.51B derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $1.41B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.76B derived: sum of 2 quarters · filed 2026-02-26 | $4.06B derived: sum of 3 quarters · filed 2026-02-26 | $5.37B 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $1.35B 10-Q · filed 2025-10-31 | $2.65B derived: sum of 2 quarters · filed 2025-10-31 | $3.97B 10-Q · filed 2025-10-31 | $5.21B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $1.30B 10-Q · filed 2025-08-06 | $2.62B 10-Q · filed 2025-08-06 | $3.86B derived: sum of 3 quarters · filed 2026-02-26 | $5.07B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $1.32B 10-Q · filed 2025-05-01 | $2.56B derived: sum of 2 quarters · filed 2026-02-26 | $3.77B derived: sum of 3 quarters · filed 2026-02-26 | $4.96B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $1.25B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.45B derived: sum of 2 quarters · filed 2026-02-26 | $3.64B derived: sum of 3 quarters · filed 2026-02-26 | $4.80B 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $1.21B 10-Q · filed 2024-11-01 | $2.39B derived: sum of 2 quarters · filed 2024-11-01 | $3.55B 10-Q · filed 2024-11-01 | $4.69B derived: sum of 4 quarters · filed 2024-11-01 | ||||
| 2023-06-30 | $1.19B 10-Q · filed 2024-08-06 | $2.35B 10-Q · filed 2024-08-06 | $3.48B derived: sum of 3 quarters · filed 2024-08-06 | $4.57B derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | $1.16B 10-Q · filed 2024-05-02 | $2.30B derived: sum of 2 quarters · filed 2024-05-02 | $3.39B derived: sum of 3 quarters · filed 2024-05-02 | $4.45B derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $1.14B 10-K · filed 2023-02-27 | $2.23B derived: sum of 2 quarters · filed 2023-11-01 | $3.29B derived: sum of 3 quarters · filed 2023-11-01 | $4.35B 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $1.09B 10-Q · filed 2023-11-01 | $2.15B derived: sum of 2 quarters · filed 2023-11-01 | $3.21B 10-Q · filed 2023-11-01 | $4.25B derived: sum of 4 quarters · filed 2023-11-01 | ||||
| 2022-06-30 | $1.06B 10-Q · filed 2023-08-04 | $1.33B 10-Q · filed 2022-08-04 | $2.12B 10-Q · filed 2023-08-04 | $2.66B 10-Q · filed 2022-08-04 | $3.16B derived: sum of 3 quarters · filed 2023-08-04 | $4.18B derived: sum of 4 quarters · filed 2023-08-04 | ||
| 2022-03-31 | $1.06B 10-Q · filed 2023-05-03 | $1.33B 10-Q · filed 2022-05-03 | $2.10B derived: sum of 2 quarters · filed 2023-05-03 | $3.11B derived: sum of 3 quarters · filed 2023-05-03 | $4.11B derived: sum of 4 quarters · filed 2023-05-03 | |||
| 2021-12-31 | $1.04B 10-K · filed 2023-02-27 | $2.05B derived: sum of 2 quarters · filed 2023-02-27 | $3.06B derived: sum of 3 quarters · filed 2023-02-27 | $4.01B 10-K · filed 2024-02-28 | $5.12B 10-K · filed 2022-02-25 | |||
| 2021-09-30 | $1.01B 10-K · filed 2023-02-27 | $1.28B 10-Q · filed 2021-11-02 | $2.01B derived: sum of 2 quarters · filed 2023-02-27 | $2.97B 10-Q · filed 2022-11-02 | $3.80B 10-Q · filed 2021-11-02 | $4.19B derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2021-06-30 | $1.00B 10-K · filed 2023-02-27 | $1.29B 10-Q · filed 2021-08-03 | $2.52B 10-Q · filed 2022-08-04 | $3.18B derived: sum of 3 quarters · filed 2023-02-27 | $4.35B derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-03-31 | $959.90M 10-K · filed 2023-02-27 | $1.23B 10-Q · filed 2021-05-04 | $2.17B derived: sum of 2 quarters · filed 2023-02-27 | $3.35B derived: sum of 3 quarters · filed 2023-02-27 | $4.42B derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2020-12-31 | $1.21B 10-K · filed 2021-02-26 | $2.39B derived: sum of 2 quarters · filed 2021-11-02 | $3.46B derived: sum of 3 quarters · filed 2021-11-02 | $3.57B 10-K · filed 2023-02-27 | $4.64B 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $1.17B 10-Q · filed 2021-11-02 | $2.25B derived: sum of 2 quarters · filed 2021-11-02 | $3.43B 10-Q · filed 2021-11-02 | $4.61B derived: sum of 4 quarters · filed 2021-11-02 | ||||
| 2020-06-30 | $1.07B 10-Q · filed 2021-08-03 | $2.26B 10-Q · filed 2021-08-03 | $3.44B derived: sum of 3 quarters · filed 2021-08-03 | $4.60B derived: sum of 4 quarters · filed 2021-08-03 | ||||
| 2020-03-31 | $1.18B 10-Q · filed 2021-05-04 | $2.37B derived: sum of 2 quarters · filed 2021-05-04 | $3.53B derived: sum of 3 quarters · filed 2021-05-04 | $4.66B derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-12-31 | $1.18B 10-K · filed 2021-02-26 | $2.35B derived: sum of 2 quarters · filed 2021-02-26 | $3.48B derived: sum of 3 quarters · filed 2021-02-26 | $4.61B 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $1.16B 10-K · filed 2021-02-26 | $2.30B derived: sum of 2 quarters · filed 2021-02-26 | $3.42B 10-Q · filed 2020-11-02 | $4.52B derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $1.14B 10-K · filed 2021-02-26 | $2.26B 10-Q · filed 2020-07-31 | $3.35B derived: sum of 3 quarters · filed 2021-02-26 | $4.42B derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $1.12B 10-K · filed 2021-02-26 | $2.22B derived: sum of 2 quarters · filed 2021-02-26 | $3.29B derived: sum of 3 quarters · filed 2021-02-26 | $4.36B derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $1.10B 10-K · filed 2020-02-27 | $2.16B derived: sum of 2 quarters · filed 2020-02-27 | $3.23B derived: sum of 3 quarters · filed 2020-02-27 | $4.28B 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $1.07B 10-K · filed 2020-02-27 | $2.14B derived: sum of 2 quarters · filed 2020-02-27 | $3.18B 10-Q · filed 2019-10-31 | $4.19B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $1.07B 10-K · filed 2020-02-27 | $2.11B 10-Q · filed 2019-07-31 | $3.12B derived: sum of 3 quarters · filed 2020-02-27 | $4.10B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $1.05B 10-K · filed 2020-02-27 | $2.05B derived: sum of 2 quarters · filed 2020-02-27 | $3.04B derived: sum of 3 quarters · filed 2020-02-27 | $4.00B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $1.01B 10-K · filed 2019-02-27 | $1.99B derived: sum of 2 quarters · filed 2019-02-27 | $2.96B derived: sum of 3 quarters · filed 2019-02-27 | $3.91B 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $981.60M 10-K · filed 2019-02-27 | $1.95B derived: sum of 2 quarters · filed 2019-02-27 | $2.91B 10-Q · filed 2018-10-31 | |||||
| 2017-06-30 | $966.40M 10-K · filed 2019-02-27 | $1.92B derived: sum of 2 quarters · filed 2019-02-27 | ||||||
| 2017-03-31 | $957.10M 10-K · filed 2019-02-27 | |||||||
| 2016-12-31 | $3.64B 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |